Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel hydrogenation route for dibenzyl ethylenediamine acetate. High purity >99%, low cost, scalable pharma intermediate manufacturing.
Patent CN110511214A reveals a ruthenium-catalyzed route for diamine heterocycles, offering cost reduction and scalable supply for antitumor pharmaceutical intermediates.
Patent CN103145581A discloses soluble aromatic diamines with imide structures for advanced electronic materials, offering superior thermal stability and processability.
Patent CN104529803B reveals a novel amide synthesis route using triethylenediamine. Achieve cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN106748826B details high-purity TMAEEA production. Offers supply chain reliability and cost efficiency for polyurethane manufacturers globally.
Patent CN102516351A details novel ursolic acid derivatives with enhanced anti-cancer activity and reduced toxicity, offering cost reduction in API manufacturing.
Patent CN102408342B reveals a novel fluorene-based diamine synthesis offering enhanced solubility and photoelectric properties for high-performance polyimides.
Patent CN112778211A reveals a novel diamine synthesis improving polyimide solubility and thermal stability. Discover cost-effective manufacturing and supply chain advantages.
Patent CN120682230A reveals novel quinazolinone synthesis. Offers improved antitumor activity and scalable manufacturing for pharmaceutical intermediate supply chains.
Patent CN112679418A reveals a one-step Suzuki coupling for high-purity diamines, offering cost-effective solutions for polyimide and agrochemical manufacturing.
Patent CN111909038A introduces a safe, low-pressure Schiff base catalyzed route for phenylenediamine, offering significant cost and safety advantages over traditional nitration.
Advanced synthesis of arylamine nitrogen mustard derivatives via patent CN106631857A. Offers reduced toxicity and enhanced therapeutic index for pharmaceutical manufacturing.
Patent CN119039150A details a novel Negishi coupling route for high-purity Cobicistat intermediates, offering significant supply chain and cost advantages for manufacturers.
Patent CN103502208B reveals mild diamine synthesis avoiding Birch reduction. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN105367427B reveals metal-free NHC catalysis for chiral 1,2-diamines. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN106146316A reveals high-selectivity boron catalysis for 1,2-diaryl ethylenediamines. Enables cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Patent CN105837525A reveals a mild copper-catalyzed route for antibacterial triazine intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111440205B reveals a novel diboronic acid diol ester enabling high-yield, 99% ee chiral 1,2-diamine synthesis with recyclable reagents for cost-effective manufacturing.
Patent CN118125939B reveals metal-free diamination. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable high-purity processes.
Patent CN107629051B reveals a novel three-step carbonylation route for evodiamine, offering streamlined production and cost advantages for pharmaceutical intermediates.